Understanding Oncology Drug Interactions

Understanding Oncology Drug Interactions (RN-AH SPOC)

Originally presented October 10, 2018 as part of the UNC Cancer Network RN and Allied Health Lecture Series. This Self-Paced, Online Course expired November 6, 2019.

This is a Non-Credit course and does NOT offer continuing education credits.

Presenter

Katherine Morgan, PharmD, BCOP, CPP
Oncology Clinical Specialist, Outpatient Genitourinary and Neuro Oncology
UNC Medical Center
Assistant Professor, Clinical Education
UNC Eshelman School of Pharmacy
University of North Carolina at Chapel Hill

Understanding Oncology Drug Interactions

The narrow therapeutic index of oncology drugs makes understanding drug interactions critical for the safe and effective treatment of cancer patients. Small changes in the pharmacodynamics or pharmacokinetics of the drug can decrease efficacy or increase toxicity of the cancer drug potentially causing harm to patients during treatment.

Learning Outcomes

  • Discuss the importance of identifying drug-drug interactions in patients receiving cancer directed therapy
  • Describe the pharmacokinetic and pharmacodynamic factors that are impacted by drug-drug interactions
  • Identify important drug- drug interactions that could increase toxicity or decrease efficacy of a cancer therapy and how to manage them

Credits Offered

  • 1.0 ANCC (CNE) hours of study.
  • 1 ASRT Category A CE Credit
  • General Participation

Requirements

To receive credit for this course, you must:

  1. Watch a lecture video recording.
  2. Complete the lecture post test and obtain a passing score of 80% or higher.
  3. Complete the course evaluation.
  4. Select credit type.

Estimated course completion time: 1 hour

Disclosures

This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. Thomas Shea consults for Spectrum Pharma and receives research support from Millennium, Otsuka, GSK, BMS, Novartis and Seattle Genetics. Dr. James Coghill, MD, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.

The presenter, Katherine Morgan, PharmD, BCOP, CPP, has no conflicts of interest relevant to this presentation.

Accreditation

This is a Non-Credit course and does NOT offer continuing education credits.

Disclaimer

Please note: This course was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional.